Literature DB >> 7353000

Pentobarbital sodium inhibits calcium uptake in vascular smooth muscle.

B T Altura, P D Turlapaty, B M Altura.   

Abstract

This report demonstrates that the commonly used anesthetic agent, pentobarbital sodium, in concentrations of 1 . 10(-4) to 2 . 10(-3) M inhibits calcium (Ca2+) uptake in both rat aortic and portal venous smooth muscle. The data indicate that total exchangeable Ca2+ in portal vein is reduced by about 15% in 1 . 10(-4) M pentobarbital sodium, while the intracellular exchangeable Ca2+ is reduced by 24%. On the other hand, in aortic smooth muscle, while 5--20 . 10(-4) M pentobarbital sodium reduces total exchangeable Ca2+ by about 15%, intracellular Ca2+ is reduced by 22% in 5 . 10(-4) M pentobarbital sodium and by 38% in 2 . 10(-3) M pentobarbital sodium. The present studies thus reveal that concentrations of pentobarbital sodium known to be present during induction of surgical anesthesia can exert significant inhibitory effects on exchangeability and transmembrane movement of Ca2+ in at least two different types of blood vessels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7353000     DOI: 10.1016/0005-2736(80)90093-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Comparison of the vasodilator effects of thiopentone and pentobarbitone.

Authors:  T Yakushiji; K Nakamura; Y Hatano; K Mori
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

2.  Ca2+ uptake and distribution in alloxan-diabetic rat arterial and venous smooth muscle.

Authors:  P D Turlapaty; B T Altura; B M Altura
Journal:  Experientia       Date:  1980-11-15

3.  Reversible inhibition of protein synthesis in lung by halothane.

Authors:  D E Rannels; R Christopherson; C A Watkins
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

4.  The relaxing effects of barbiturates in vascular smooth muscle of rat aorta.

Authors:  M Nishiwada; K Nakamura; Y Hatano; K Mori
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.